SLC6A3 and Alzheimer disease: In this study, we evaluated the relationship between striatal dopamine transporter (DAT) uptake, BF volume, WMH burden, and clinical symptoms in patients with carefully phenotyped AD, DLB, and mixed dementia (AD+DLB).